Log in to search using one of your social media accounts:

 

UCLA study describes structure of tumor herpes virus associated with Kaposi ’s sarcoma
UCLA researchers have provided the first description of the structure of the herpes virus associated with Kaposi ’s sarcoma, a type of cancer.The discovery answers important questions about how the virus spreads and provides a potential roadmap for the development of antiviral drugs to combat both that virus and the more common Epstein-Barr virus, which is present in more than 90 percent of the adult population and is believed to have a nearly identical structure.In the study, published in the journal  Nature, the UCLA team showed in the laboratory that an inhibitor could be developed to break down the herpes vi...
Source: UCLA Newsroom: Health Sciences - January 20, 2018 Category: Universities & Medical Training Source Type: news

Medical News Today: Head and neck cancer: Acid reflux may raise risk in seniors
A new study finds a strong association between acid reflux and cancers of the respiratory and upper digestive tracts in older adults. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 30, 2017 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Anesthesia for Head and Neck Cancer Surgery Anesthesia for Head and Neck Cancer Surgery
Head and neck cancer patients may present with a difficult airway, as well as significant comorbidities. How should they be assessed and managed for anesthesia?BJA Education (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 29, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Nanobiotix ’s nanoparticle-immunotherapy trial wins FDA approval
Nanobiotix (EMA:NANO) said today that the FDA has approved its IND application for a cancer trial combining its radiotherapy-activated nanoparticle tech with an anti-PD1 antibody. The Phase I/II trial is slated to evaluate the safety and efficacy of Nanobiotix’s NBTXR3 product administered with checkpoint inhibitors in three groups of patients with recurrent or metastatic head and neck squamous cell carcinoma or with metastatic non-small cell lung cancer. Get the full story at our sister site, Drug Delivery Business News. The post Nanobiotix’s nanoparticle-immunotherapy trial wins FDA approval appeare...
Source: Mass Device - December 26, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Food & Drug Administration (FDA) Oncology Pharmaceuticals Wall Street Beat nanobiotix Source Type: news

GERD Associated with Increased Risk for Head and Neck Cancers
Gastroesophageal reflux disease (GERD) is associated with significantly increased risk for cancers of the upper aerodigestive tract in older adults, according to a case-control... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 22, 2017 Category: Primary Care Source Type: news

Chronic Heartburn Tied to Higher Odds for Head, Neck Cancers
New research suggests people with chronic acid reflux might have higher odds for even more dangerous foes -- head and neck cancers (Source: WebMD Health)
Source: WebMD Health - December 21, 2017 Category: Consumer Health News Source Type: news

Chronic Heartburn Tied to Higher Odds for Head, Neck Cancers
Source: HealthDay Related MedlinePlus Pages: GERD, Head and Neck Cancer (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 21, 2017 Category: Consumer Health News Source Type: news

Chronic Heartburn Tied to Higher Odds for Head, Neck Cancers
THURSDAY, Dec. 21, 2017 -- Millions of American seniors suffer the discomfort of chronic acid reflux. Now, new research suggests the condition might raise their odds for even more dangerous foes -- head and neck cancers. The research can't prove... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 21, 2017 Category: General Medicine Source Type: news

Acid reflux associated with head and neck cancers in older adults
(JAMA Network) Acid reflux was associated with cancer of the respiratory and upper digestive tracts in older adults. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 21, 2017 Category: International Medicine & Public Health Source Type: news

A systematic review of alcohol interventions for people living with and beyond cancer
Conclusion This review highlights there is a lack of interventions which have a specific focus on reducing how much alcohol people are drinking following a diagnosis for cancer.  Alcohol use can increase the risk of secondary or recurrent cancer, especially in people who have been diagnosed with breast cancer, and head and neck cancers. Therefore, there is a need for more research to explore the potential for interventions to encourage people who have been diagnosed with cancer to drink less alcohol, which can reduce this risk. Further Information Contact details for corresponding author: Dr Grant J. McGeechan, C1.1...
Source: Alcohol Research UK - December 20, 2017 Category: Addiction Authors: admin Tags: Alcohol Insights Source Type: news

Head and Neck Cancer Survivors Have Long-lasting Cognitive Problems Head and Neck Cancer Survivors Have Long-lasting Cognitive Problems
Patients who survive head and neck cancer may be more likely to experience declines in cognitive function than people who don ’ t have these tumors, a recent study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 14, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Head and neck cancer survivors have long-lasting cognitive problems
(Reuters Health) - Patients who survive head and neck cancer may be more likely to experience declines in cognitive function than people who don ’t have these tumors, a recent study suggests. (Source: Reuters: Health)
Source: Reuters: Health - December 13, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Head and neck cancer researchers to convene for Multidisciplinary Care Symposium February 15-17
(American Society for Radiation Oncology) Researchers will present peer-reviewed abstracts on new combination therapies, targeted therapies, immunotherapy, advanced radiation and surgical techniques, new staging systems, treatment guidelines and supportive care. Panel and case discussions will feature leading experts in head and neck cancer, including keynote speakers Julie E. Bauman, MD, MPH, of the University of Arizona in Tucson; Brian O'Sullivan, MD, FASTRO, of Princess Margaret Hospital in Toronto; and Carol Rossier Bradford, MD, of the University of Michigan Health System in Ann Arbor. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 5, 2017 Category: International Medicine & Public Health Source Type: news

Pretreatment Cognitive Impairment Is Common in Patients With Head and Neck Cancer
Results from a study of patients with newly diagnosed head and neck cancer indicate that cognitive screening should be incorporated into pretreatment assessment for patients in order to improve outcomes. (Source: CancerNetwork)
Source: CancerNetwork - December 1, 2017 Category: Cancer & Oncology Authors: Bryant Furlow Tags: Head & Neck Cancer News Source Type: news

Smoking, drinking worsen prognosis for head and neck cancers
(Reuters Health) - People with head and neck cancers who smoke and drink are much more likely to die with these tumors than nonsmokers and teetotalers, a recent study suggests. (Source: Reuters: Health)
Source: Reuters: Health - December 1, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Tobacco Smoking Associated with Poor Survival Following Head and Neck Cancer Diagnosis
Researchers found a statistically significant difference in median survival time between smokers and nonsmokers at diagnosis of head and neck squamous cell carcinoma. (Source: CancerNetwork)
Source: CancerNetwork - November 30, 2017 Category: Cancer & Oncology Authors: Bryant Furlow Tags: Head & Neck Cancer News Source Type: news

Invasive cells in head and neck tumors predict cancer spread
(Massachusetts Eye and Ear Infirmary) Head and neck tumors that contain cells undergoing a partial epithelial-to-mesenchymal transition --   which transforms them from neatly organized blocks into irregular structures that extrude into the surrounding environment -- are more likely to invade and spread to other parts of the body, according to a new study led by researchers from Mass. Eye and Ear, Massachusetts General Hospital (MGH) and the Broad Institute of MIT and Harvard. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 30, 2017 Category: Cancer & Oncology Source Type: news

Immunotherapy research for head and neck cancers gets boost from V Foundation grant
(University of California - San Diego) A team of University of California San Diego School of Medicine and Moores Cancer Center researchers studying new drugs designed to break resistance to cancer immunotherapy has been awarded a V Foundation for Cancer Research translational grant of $600,000 over three years. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 27, 2017 Category: Cancer & Oncology Source Type: news

Cancer Doctors Cite Risks of Drinking Alcohol
Drinking alcohol, even modest amounts, increases the risk of breast cancer and other cancers. (Source: NYT Health)
Source: NYT Health - November 7, 2017 Category: Consumer Health News Authors: RONI CARYN RABIN Tags: Head and Neck Cancer Breast Cancer Esophageal Cancer Mouth Colon and Colorectal Cancer Liver Cancer Alcoholic Beverages Alcohol Abuse Advertising and Marketing Source Type: news

“Bubbles” Boost Search for Treatment to Aid Head and Neck Cancer Patients
A scientific team at the University of Rochester is using innovative technology to discover preventative treatments for salivary gland radiation damage typical for head and neck cancer patients —and recently received a $3.8 million National Institutes of Health grant to support their investigation. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - October 26, 2017 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

Proton therapy lowers treatment side effects in pediatric head and neck cancer patients
(University of Pennsylvania School of Medicine) Pediatric patients with head and neck cancer can be treated with proton beam therapy (PBT) instead of traditional photon radiation, and it will result in similar outcomes with less impact on quality of life. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 23, 2017 Category: Cancer & Oncology Source Type: news

Medical News Today: Head and neck cancer: Could oral sex raise your risk?
Researchers have found a link between oral sex and smoking and an increased risk of a type head and neck cancer triggered by the human papillomavirus. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 21, 2017 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Oral Sex Plus Smoking a Cancer Danger for Men
Risk of head and neck tumors tied to HPV infection jumps to 15 percent for this group, study finds (Source: WebMD Health)
Source: WebMD Health - October 20, 2017 Category: Consumer Health News Source Type: news

Men who perform oral sex on women 'more at risk of mouth and throat cancers'
Conclusion This study uses a large amount of national data to give us an idea about which groups of people have the greatest risk of carrying potentially cancer-causing oral HPV . But while oral HPV may increase people's risk of mouth and throat cancers, the actual number who would go on to develop cancer is extremely small. This study has limitations, which are worth bearing in mind: It only looked at whether people had oral HPV at a single point in time. This makes it difficult to know at what point they became infected and how much this could be down to other risk factors such as smoking, oral sex and number of partne...
Source: NHS News Feed - October 20, 2017 Category: Consumer Health News Tags: Cancer Source Type: news

Oral Sex Plus Smoking a Cancer Danger for Men
Risk of head and neck tumors tied to HPV infection jumps to 15 percent for this group, study findsSource: HealthDay Related MedlinePlus Pages: HPV, Men's Health, Smoking (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 20, 2017 Category: Consumer Health News Source Type: news

Oral Sex Plus Smoking a Cancer Danger for Men
FRIDAY, Oct. 20, 2017 -- Smoking and oral sex may be a deadly combo that raises a man's risk for head and neck cancer, a new study suggests. The key factor is transmission of oral strains of the cancer-linked human papillomavirus (HPV), which can... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 20, 2017 Category: General Medicine Source Type: news

Oral Sex Plus Smoking a Cancer Danger for Men
Risk of head and neck tumors tied to HPV infection jumps to 15 percent for this group, study finds (Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - October 20, 2017 Category: Cancer & Oncology Source Type: news

Varian launches Halcyon treatment in EU
Varian Medical (NYSE:VAR) said today it launched its Halcyon image-guided volumetric intensity modulated radiotherapy cancer treatment system in the European Union, with the 1st patient being treated in Blegium. The Palo Alto, Calif.-based company said its Halcyon IMRT system features improvements that make it more comfortable for patients and streamline operator’s workflow, only requiring 9 steps from start to treatment, down from 30 steps in legacy machines. Varian said the device is designed to handle “the majority” of cancer patients, including individuals with prostate, breast, head & neck and ot...
Source: Mass Device - October 19, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Oncology Varian Medical Systems Source Type: news

7 Million American Men Carry Cancer-Causing HPV
The incidence of mouth and throat cancers caused by the human papillomavirus in men has now surpassed the incidence of HPV-related cervical cancers in women. (Source: NYT Health)
Source: NYT Health - October 18, 2017 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Head and Neck Cancer Human Papillomavirus (HPV) Sexually Transmitted Diseases Throat Smoking and Tobacco Men and Boys Vaccination and Immunization Infections Source Type: news

HPV causing cancer of head, neck affects more men than women in U.S.
A U.S. study suggests that 1 in 9 men has an oral HPV infection. HPV-related head and neck cancers are on the rise. (Source: CBC | Health)
Source: CBC | Health - October 17, 2017 Category: Consumer Health News Tags: News/Health Source Type: news

7 Million American Men Carry Cancer-Causing HPV Virus
The incidence of mouth and throat cancers caused by the human papilloma virus in men has now surpassed the incidence of HPV-related cervical cancers in women. (Source: NYT Health)
Source: NYT Health - October 16, 2017 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Head and Neck Cancer Human Papillomavirus (HPV) Sexually Transmitted Diseases Throat Smoking and Tobacco Men and Boys Vaccination and Immunization Infections Source Type: news

In global first, Penn using glowing tumor dye to identify cancerous lymph nodes
(University of Pennsylvania School of Medicine) Surgeons at Penn Medicine are using a fluorescent dye that makes cancerous cells glow in hopes of identifying suspicious lymph nodes during head and neck cancer procedures. Led by Jason G. Newman, MD, FACS, an associate professor of Otorhinolaryngology in the Perelman School of Medicine at the University of Pennsylvania, the study is the first in the world to look at the effectiveness of intraoperative molecular imaging (IMI) of lymph nodes in patients with head and neck cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 10, 2017 Category: International Medicine & Public Health Source Type: news

7 medtech stories we missed this week: Sept. 29, 2017
[Image from unsplash.com]From EOI getting FDA clearance to Sanuwave’s new joint venture agreement, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. EOI wins FDA nod for FLXfit15 expandable cage EOI announced in a Sept. 28 press release that it has received FDA 510(k) clearance for its FLXfit 15. The clearance will help enhance the company’s FLXfir 3D expandable cage system and help expand the surgeon’s flexibility and capability by offering different length options. 2. ivWatch inks distribution deal with Terumo ivWatch has recently signed a licensing...
Source: Mass Device - September 29, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Business/Financial News Clinical Trials Diagnostics Food & Drug Administration (FDA) Cefaly EOI ivwatch Lombard Medical MedTech Mortise Medical Mundimed Sanuwave Terumo Varian Medical Systems Source Type: news

Drug combination may improve impact of immunotherapy in head and neck cancer
(University of California - San Diego) Checkpoint inhibitor-based immunotherapy has been shown to be very effective in recurrent and metastatic head and neck cancer but only in a minority of patients. University of California San Diego School of Medicine researchers may have found a way to double down on immunotherapy's effectiveness. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 21, 2017 Category: International Medicine & Public Health Source Type: news

Short dental implants: A scoping review of the literature for patients with head and neck cancer
ConclusionsShort dental implants (6 mm to 8 mm) can be used successfully to support single or multiple fixed reconstructions or overdentures in atrophic maxillae and mandibles. The use of short dental implants lessens the need for advanced and complicated surgical bone augmentation procedures, which reduces complications, costs, treatment time, and morbidity. Short implants could be an alternative in the rehabilitation of patients with cancer. (Source: Dental Technology Blog)
Source: Dental Technology Blog - September 20, 2017 Category: Dentistry Source Type: news

Tailored Treatment for Head-and-Neck Cancer Mystery
Treatment TermsHead and Neck Cancer Overview Rob Vaughn found a lump on his neck that turned out to be cancer that had spread from somewhere else in his body. The trouble was, doctors couldn ’t find the original site of the cancer. That made his treatment decisions difficult -- until two Duke specialists offered him options, including the option for watchful waiting instead of extensive treatment. Hero Image20170914_robvaughn_neckcancer_083_herocrop.jpg Preview Image Content Blocks Header A Search for the Source of Cancer ContentVaughn, a Charlotte, NC, father of two, was 47 and in good health when he felt th...
Source: dukehealth.org: Duke Health News - September 15, 2017 Category: Consumer Health News Authors: mf205 at duke.edu Source Type: news

Tactile Medical shareholders ready $109 million offering
Tactile Systems Technology said this week that its investors have priced a new offering, looking to raise approximately $109 million. In the offering, investors in the Minneapolis, Minn.-based company will look to offer 3.3 million shares of common stock at approximately $33 per share. The offering will also include an underwriters option to purchase an additional 495,000 shares, which could bring in an additional $16.3 million. Tactile said it will receive no proceeds from the offering, which is expected to close today. William Blair & Co. and Piper Jaffray & Co. are acting as joint book runners, with Cannaco...
Source: Mass Device - September 15, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Tactile Systems Technology Source Type: news

Monopar receives licence to develop Onxeo ’s Validive oral mucositis treatment
Onxeo has granted a global exclusive licence to Monopar Therapeutics for its Validive (clonidine mucoadhesive buccal) tablet used to treat severe oral mucositis induced by radiotherapy or chemotherapy in patients suffering from head and neck cancer. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 13, 2017 Category: Pharmaceuticals Source Type: news

Cancer drug stimulates tripolar mode of mitosis
(Helmholtz Zentrum M ü nchen - German Research Center for Environmental Health) Taxanes inhibit cell division and make cancer cells sensitive to radiation therapy. A current study has investigated the underlying mechanisms of this action - and which biomarkers may be useful for predicting the success of therapy. The study, published in the journal Oncogene, was carried out within the framework of the Clinical Cooperation Group Personalized Radiotherapy in Head and Neck Cancer at Helmholtz Zentrum M ü nchen and Munich University Hospital. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 12, 2017 Category: Biology Source Type: news

KEYNOTE-040 evaluates pembrolizumab in head and neck cancer
(European Society for Medical Oncology) Immunotherapy with the checkpoint inhibitor pembrolizumab may be a better option than standard treatments for patients whose head and neck cancer has spread, or recurred after an initial round of chemotherapy, according to results of the Keynote-040 trial presented at the ESMO 2017 Congress in Madrid. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 11, 2017 Category: Cancer & Oncology Source Type: news

World Trade Center responders might face greater risk of HPV throat and tongue cancer
(Rutgers University) Researchers at Rutgers University -- investigating the causes of head and neck cancers in World Trade Center rescue and recovery workers -- will take the lead in a study to determine whether the responders are at a greater risk for human papillomavirus (HPV)-related throat and tongue cancer because of their exposure to toxic dust and debris. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 8, 2017 Category: International Medicine & Public Health Source Type: news

From bed to bench and back to bed: Mimicking how HPV-positive cancer responds to treatment
(Medical University of South Carolina) Patients with head and neck cancer who are also positive for human papilloma virus (HPV) are known to have a better prognosis compared to patients with HPV-negative disease, independent of therapeutic intervention. Researchers at the Medical University of South Carolina Hollings Cancer Center have discovered one reason why and have identified a peptide that, in preclinical studies, can act on the identified mechanism to improve outcomes in HPV-negative head and neck cancer. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 7, 2017 Category: Biology Source Type: news

Oral Sex Plus Smoking a Cancer Danger for Men
Risk of head and neck tumors tied to HPV infection jumps to 15 percent for this group, study finds (Source: Fertility News - Doctors Lounge)
Source: Fertility News - Doctors Lounge - September 1, 2017 Category: Reproduction Medicine Tags: Infections, Oncology, Reproductive Medicine, Preventive Medicine, News, Source Type: news

Physician experts highlight research ahead of Otolaryngology's annual meeting
(American Academy of Otolaryngology - Head and Neck Surgery) The latest research on patient preferences, quality-of-life, ear health, thyroidectomy, and other topics related to the specialty of otolaryngology will be presented in Chicago, IL, Sept. 10-13, during the AAO-HNSF 2017 Annual Meeting& OTO Experience. The 2017 Annual Meeting includes hundreds of research presentations. All abstracts to be presented are now available online. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 1, 2017 Category: Cancer & Oncology Source Type: news

After Skull Base Tumor, Dancer/Model Takes on Law School
Treatment TermsSkull base tumor Author Karen Doss Bowman Overview Victoria Vesce had surgery and 28 rounds of radiation for rare tumors in the base of her skull and in her neck. Four days after her last radiation treatment, she started law school. Hero Image20170809.vesce_.victoria.03.blog_.jpg Preview Image Content Blocks Section Header Image/Videovesce_honeybee_blog.jpg Section Features Images/Media Text Content Section Header Image/Videovesce_blog_secondary3.jpg Section Features Images/Media Text Content Header A Regional Destination for Rare Head and Neck Tumors ContentPatients from throughout the Sou...
Source: dukehealth.org: Duke Health News - August 23, 2017 Category: Consumer Health News Authors: mf205 at duke.edu Source Type: news

Cel-Sci raises $3.5m for head and neck cancer immunotherapy
Cel-Sci (NYSE:CVM) said today that it inked an agreement with institutional investors for a $3.5 million registered direct offering. The company said it plans to offer 1.75 million shares of common stock at $2.00 apiece. In a private placement, Cel-Sci will issue warrants to buy up to 1.75 million shares of common stock. For each share of stock purchased in the registered direct offering, investors in the private placement will receive an unregistered warrant to buy one share of common stock, which have an exercise price of $2.30 apiece. Get the full story at our sister site, Drug Delivery Business News...
Source: Mass Device - August 23, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Funding Roundup Oncology Pharmaceuticals Wall Street Beat cel-sci Source Type: news

Nutlin-3, a p53-Mdm2 antagonist for nasopharyngeal carcinoma treatment
(Bentham Science Publishers) Nasopharyngeal carcinoma (NPC) is a form of head and neck cancer that is highly prevalent among men in the populations of Southern China and Southeast Asia. This review will discuss the potential use of Nutlin-3 as a p53-activating drug and the future directions of its clinical research for NPC treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 23, 2017 Category: Cancer & Oncology Source Type: news

Study provides insight into link between two rare tumor syndromes
FINDINGSUCLA researchers have discovered that timing is everything when it comes to preventing a specific gene mutation in mice from developing rare and fast-growing cancerous tumors, which also affects young children. This mutation can also cause a benign tumor condition in humans in adulthood.The scientists found that when one tumor suppressor gene is turned off or inactivated during early stages of a developing mouse embryo, it induces the formation of a malignant tumor. The research demonstrates that this type of malignant tumor will not form if the gene is inactivated during later stages of nerve development. However,...
Source: UCLA Newsroom: Health Sciences - August 21, 2017 Category: Universities & Medical Training Source Type: news

FDA lifts hold on Cel-Sci's clinical trial for head and neck cancer drug
The U.S. Food and Drug Administration lifted a partial hold it placed nearly a year ago on a clinical trial for a head and neck cancer drug from Vienna-based Cel-Sci Corp. The company announced Monday morning it has received the go-ahead to resume the phase 3 clinical trial of immunotherapy drug Multikine. Cel-Sci had brought on 926 patients out of a desired 1,273 when the hold was put in place in September. The FDA instituted the hold because of an unreasonable an d significant risk of illness… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 14, 2017 Category: American Health Authors: Drew Hansen Source Type: news

Prevention of HPV-Related Oral Cancer by Dentists: Assessing the Opinion of Dutch Dental Students
Journal of Cancer Education pp 1 –8AbstractThe aim of this study is to assess dental students ’ opinions of the dentists’ role in primary prevention of human papillomavirus (HPV)-related oral cancer using a cross-sectional web-based survey. A questionnaire, containing questions about knowledge of HPV and oral cancer, confidence in head and neck examination and role of the dentist in preventing HPV-related oral cancer, was sent to all students of the Academic Centre of Dentistry Amsterdam (n = 912). One hundred and twenty-six (n = 126) students completed the questionnaire. Significantly...
Source: Dental Technology Blog - August 2, 2017 Category: Dentistry Source Type: news